Skip to content
News Center
About Us Careers News Center Contact Us Legal Video Hub iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Illumina for Startups Home

Community

2020 Vision for Genomics

Looking forward, Dr. Eric Green talks to Illumina about the future of genomics

2020 Vision for Genomics
June 1, 2018

The National Human Genome Research Institute (NHGRI) launched a new round of strategic planning to establish a 2020 vision for genomics. In celebration of National DNA Day 2018, Dr. Eric Green, Director of the NHGRI, joins us for a discussion of the Human Genome Project, the state of genomics today and where genomics is likely headed in the future.

Listen to the podcast, here.

 

Like podcasts? Curious about genomics? Discover more Illumina-produced podcasts, here.

Previous Article
Next Article

Recent Articles

It’s time to increase access to molecular testing for people with ovarian cancer
It’s time to increase access to molecular testing for people with ovarian cancer
Enriching talented scholars for public health in China
Enriching talented scholars for public health in China
Yes, it’s possible: Students visit Illumina and see their potential careers
Yes, it’s possible: Students visit Illumina and see their potential careers
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2023 Illumina, Inc. All rights reserved.